Adding Deep Front Line Myofascial Release to Selected Exercises in Patients With Knee Osteoarthritis

Knee Osteoarthritis Clinical Trial

Official title:

Effects of Adding Deep Front Line Myofascial Release to Selected Exercises in Patients With Knee Osteoarthritis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05812898
• Other study ID #: P.T.REC/012/004281
• Status: Completed
• Phase: N/A
• Start date: January 1, 2023
• Est. completion date: May 15, 2023

Study information

• Verified date: February 2024
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

the aim of the study is to investigate the effect of deep front line myofascial release to selected exercises in patients with knee osteoarthritis

Description:

: Knee osteoarthritis (KOA) also known as degenerative joint disease, is typically the result of wear and tear and progressive loss of articular cartilage. The myofascial meridian is a new approach to the facial restriction .the knee capsules, the adductor muscles and the tipialis posterior are part of the deep front line which is a line of the myofascial meridian. Exercise is the highest evidence in the treatment of knee osteoarthritis. The myofascial release is effective in the treatment of knee osteoarthritis so the study will investigate the effect of adding deep front line myofascial release to selected exercises in patients with knee osteoarthritis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: May 15, 2023
• Est. primary completion date: April 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 45 Years to 60 Years

Eligibility

Inclusion Criteria:

• Mild to moderate unilateral or bilateral medial tibiofemoral OA grade II-III (K/L).
• The age of the participants will range from 45 to 60 years old .
• BMI ranged from 20-30 kg/m2

Exclusion Criteria:

1. Severe knee OA (grade IV according to K/L classification).

2. Congenital or acquired inflammatory, rheumatic or neurological (systemic or local) diseases involving the knee.

3. Patients receiving oral or injected corticosteroids for the last 3 months .

4. History of knee surgery/fracture.

5. Patients with ACL and meniscus injury

Related Conditions & MeSH terms

• Knee Osteoarthritis
• Osteoarthritis
• Osteoarthritis, Knee

Intervention

Other:
• exercises
strengthening of the gluteus maximus and medius, calf muscles stretching for calf and hamstring muscles
• myofascial release
myofascial release using instrument assisted soft tissue mobilization

Locations

Country	Name	City	State
Egypt	Hoda Mohamed Ahmed	Giza

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	pain intensity	The scale that will be used the visual analogue scale;each subject will instructed to record pain intensity on line of 100mm. Starting from no pain on the leftto the most sever pain imaginable on the right Patient will choose the point which describe his pain.the more the score toward the end the more severe pain	up to four weeks
Primary	function	The Arabic version of reduced Western Ontario and McMasters University Osteoarthritis Index (ArWOMAC) index will be used to measure functional disability.is a self-administered questionnaire consisting of 24 items divided into 3 subscales: Pain (5 items): During walking, using stairs, in bed, sitting or lying, and standing upright; Stiffness (2 items): After first waking and later in the day Physical Function (17 items).The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function.Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations	up to four weeks
Primary	rang of motion	using digital inclinometer	up to four weeks
Primary	joint position sense	using digital inclinometer for target angle 30 degree knee flexion	up to four weeks